Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

0

PDL BioPharma Issues Q2 Royalty Guidance

PDL BioPharma (NASDAQ: PDLI  ) is expecting a healthy bump in its royalty revenue for the current quarter, which ends on June 30. The company has issued guidance for the period, estimating that it will take in royalty revenue of around $143 million. That would represent a 13% increase over the Q2 2012 figure of $126 million.

PDL BioPharma's optimism derives from the relatively robust sales of the key pharmaceutical products it draws revenue from. The company said sales of treatments made by key customer Genentech climbed in Q1. Genentech manufactures prominent drugs such as Avastin and Kadcyla. In addition, PDL BioPharma said sales of Biogen Idec's multiple sclerosis medication Tysabri grew by 12% on a year-over-year basis in Q1.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2484226, ~/Articles/ArticleHandler.aspx, 6/30/2015 4:10:37 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Eric Volkman
TMFVolkman

Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.

Today's Market

updated Moments ago Sponsored by:
DOW 17,658.58 62.23 0.35%
S&P 500 2,063.47 5.83 0.28%
NASD 4,995.83 37.37 0.75%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

6/30/2015 3:55 PM
PDLI $6.42 Up +0.06 +0.94%
PDL BioPharma CAPS Rating: ****

Advertisement